Seasonal Influenza Vaccines Market

Seasonal influenza is an acute viral infection, which can easily spread from person to person. In addition, seasonal influenza occurs during winter and can affect a person of any age group. Vaccination against seasonal influenza is known as seasonal influenza vaccine.

Seasonal Influenza Vaccines Market contains market size and forecasts of Seasonal Influenza Vaccines in global, including the following market information:

• Global Seasonal Influenza Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Seasonal Influenza Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Seasonal Influenza Vaccines companies in 2021 (%)

The global Seasonal Influenza Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Type A (H1N1) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Seasonal Influenza Vaccines include GlaxoSmithKline plc, Sinovac Biotech Ltd, Changsheng Bio-Technology, Ccbio SA, Aleph Biomedical, Sanofi, Jiangsu Simcere Vaxtec Bio-pharmaceutical, Dalian Hissen Bio-pharm and Abbott Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Seasonal Influenza Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Seasonal Influenza Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Seasonal Influenza Vaccines Market Segment Percentages, by Type, 2021 (%)

• Type A (H1N1)
• Type A (H3N2)
• Type B

Global Seasonal Influenza Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Seasonal Influenza Vaccines Market Segment Percentages, by Application, 2021 (%)

• Pediatrics
• Adolescence
• Adults
• Elderly

Global Seasonal Influenza Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Seasonal Influenza Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Seasonal Influenza Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Seasonal Influenza Vaccines revenues share in global market, 2021 (%)
• Key companies Seasonal Influenza Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Seasonal Influenza Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline plc
• Sinovac Biotech Ltd
• Changsheng Bio-Technology
• Ccbio SA
• Aleph Biomedical
• Sanofi
• Jiangsu Simcere Vaxtec Bio-pharmaceutical
• Dalian Hissen Bio-pharm
• Abbott Laboratories
• Novartis International AG